3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
10
Recruiting
2
No longer available
2
Unknown
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
15
Carcinoma, Hepatocellular
8
Neoplasm Metastasis
3
Rectal Neoplasms
2
Melanoma
2
Cholangiocarcinoma
2
Advanced Colorectal Cancer
2
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Tertiary Lymphoid Structures
1
TAS 102
1
Stomach Neoplasms
1
Sarcoma
1
Mesothelioma, Malignant
1
Liver Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastro-enteropancreatic neuroendocrine tumor
1
Fatigue
1
Colorectal Cancer Metastatic
1
Colorectal Cancer Liver Metastases
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Biliary Tract Neoplasms
1
Asian Colorectal Cancer Patients
1
Advanced Colorectal Carcinoma
1
Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy
1
Interventions
Imatinib Mesylate
6
Laparoscopy
3
Surgical Procedures, Operative
2
spartalizumab
1
ripretinib
1
regorafenib
1
ponatinib
1
famitinib
1
apixaban
1
anlotinib
1
Thoracic Surgery, Video-Assisted
1
TH 302
1
Surveys and Questionnaires
1
Surgical Tape
1
Sunitinib
1
Rivaroxaban
1
Oxaliplatin
1
Nivolumab
1
Liver Transplantation
1
Ipilimumab
1
Interviews as Topic
1
Endoscopic Mucosal Resection
1
Dasatinib
1
Dalteparin
1
Blood Specimen Collection
1
Biopsy
1
68Ga-NOTA-RM26
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gastrointestinal Stromal Tumors
×
regorafenib
×
Clear all
NCT02365441
2023-07-07
ALT GIST
Australasian Gastro-Intestinal Trials Group
Phase 2
Unknown
78 enrolled